Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

11/11/2019
/ Publications

Published in the Red Journal, this study identified patients who benefit most from PBT in terms of predicted 30-year absolute mortality risks (AMR30) from...

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer.

11/11/2021
/ Publications
/
Chemotherapy

This study reported outcomes of 25 patients with limited-stage small cell lung cancer treated with combined proton and carbon-ion radiotherapy. Proton and...

Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum.

11/11/2021
/ Publications

A study by the MGH group reported the clinical outcomes of four patients with oligometastatic breast cancer involving the sternum who received prior...

Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.

07/02/2022
/ Publications
/
Chemotherapy

A group of researchers from Japan reported a rare case of oligorecurrent esophageal cancer in complete remission for 5 years after a course of definitive proton...

Treating breast cancer with proton therapy

23/04/2019
/ White Paper

Breast cancer (BC) is now the most commonly diagnosed cancer in women. Worldwide, an...

Proton therapy in Groningen: clinical practice and future perspectives

09/08/2021
/ Event
/
Model-based approach
Ramp-up
  • Overview of the clinical practice of proton therapy in Groningen, The Netherlands:
  • - Evolution of the number of patients per indication
  • - Model-based...

Treating thoracic cancers with proton therapy

05/06/2019
/ White Paper
/
Chemotherapy

Worldwide, lung cancer is the most common cancer among men in both incidence and...

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer.

13/09/2022
/ Publications
/
Dosimetry

Published by the NCC group, Korea, this study reported clinical outcomes and dosimetry comparison of 289 patients with stage I NSCLC treated with protons (n=112...

Treating Hodgkin and non-Hodgkin lymphoma with proton therapy

22/12/2020
/ White Paper
/
Pencil Beam Scanning - PBS
VMAT

Proton therapy is different from photon-based radiotherapy. Because of their unique physical properties, protons have no ‘exit’ dose and very little ‘entrance’...

High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.

15/11/2022
/ Publications
/
IMPT
IMRT

This is a study protocol details a randomized trial taking place in Thailand with multiple centers comparing IMPT and IMRT for stage II–IVA squamous thoracic...